Related Experiment Video
Updated: Aug 13, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Deformylase as a novel antibacterial target
1Versicor, 34790 Ardentech Court, 93455, tel: +1 510 739 3001 fax: +1 510 739 3050, Fremont, CA, USA
Drug Discovery Today
|September 8, 2001
Summary
Novel antibacterial drug discovery is advancing with bacterial genomics, highlighting peptide deformylase as a key, recently re-evaluated target. Understanding its properties is crucial for developing new treatments.
Area of Science:
- Bacterial genomics
- Drug discovery
- Enzymology
Background:
- Bacterial genomics offers numerous potential antibacterial drug targets, but few have yielded successful drugs.
- Peptide deformylase (PDF) was identified over 30 years ago but remained largely unexploited.
- Recent advances in understanding PDF have renewed interest in its potential as a therapeutic target.
Purpose of the Study:
- To review the properties of peptide deformylase.
- To assess its suitability as a target for novel antibacterial drug discovery.
- To discuss factors influencing its tractability and attractiveness as a target.
Main Methods:
- Literature review of bacterial genomics and peptide deformylase research.
- Analysis of published data on PDF structure and function.
- Evaluation of inhibitor activity and resistance mechanisms.
Main Results:
- Peptide deformylase is a validated target for antibacterial drug development.
- Detailed knowledge of PDF's three-dimensional structure aids inhibitor design.
- Understanding enzyme properties and resistance mechanisms is key to successful exploitation.
Conclusions:
- Peptide deformylase represents a promising target for novel antibacterial agents.
- Further research into PDF properties and inhibitor development is warranted.
- Exploiting PDF could lead to new therapeutic strategies against bacterial infections.
Related Concept Videos
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...